The Clorox Company filed a Form 10-Q with the SEC on November 2, 2026, covering the quarterly period ended September 30, 2026, and reporting first-quarter results for fiscal year 2027 on NYSE:CLX.

Key Highlights

  • Net sales of $1.905 billion for the three months ended September 30, 2026, compared to $1.429 billion for the same period in 2025, according to the filing.
  • Net earnings attributable to Clorox of $170 million for the quarter, up from $80 million in the year-ago period, the company disclosed.
  • Diluted net earnings per share of $1.39 for the three months ended September 30, 2026, versus $0.65 in the prior-year quarter, as reported in the filing.
  • Total assets of $7.832 billion as of September 30, 2026, compared to $7.794 billion as of June 30, 2026, per the balance sheet.
  • Net cash provided by operations of $143 million for the quarter, up from $93 million in the same quarter of the prior year, according to the cash flow statement.
  • Cash dividends paid to Clorox stockholders of $151 million during the three months ended September 30, 2026, matching the $151 million paid in the year-ago period.
  • 121,147,396 shares of common stock outstanding as of October 19, 2026, the filing stated.

Clorox First-Quarter Fiscal 2027 Financial Results: Revenue, Earnings, and Balance Sheet

According to the filing, Clorox reported net sales of $1.905 billion for the three months ended September 30, 2026, compared to $1.429 billion for the three months ended September 30, 2025. Cost of products sold was $1.135 billion, yielding gross profit of $770 million, versus $596 million in the prior-year quarter. Selling and administrative expenses were $290 million, advertising costs were $190 million, and interest expense rose to $52 million from $23 million year over year.

The company disclosed earnings before income taxes of $207 million, with income tax expense of $34 million, producing net earnings of $173 million. After subtracting $3 million attributable to noncontrolling interests, net earnings attributable to Clorox were $170 million. Basic and diluted net earnings per share attributable to Clorox were each $1.39, based on weighted average diluted shares outstanding of 122,027 thousand, the filing reported.

On the balance sheet as of September 30, 2026, the filing showed cash and cash equivalents of $184 million, total current assets of $1.931 billion, goodwill of $1.944 billion, and total liabilities of $7.711 billion. Long-term debt stood at $3.982 billion. Total Clorox stockholders' equity reflected a deficit of $39 million, compared to positive equity of $90 million as of June 30, 2026. The filing noted 130,741,461 shares issued and 120,938,184 shares outstanding as of September 30, 2026. No treasury stock was purchased during the quarter, contrasting with $129 million in purchases during the same period of the prior year, according to the cash flow statement.

What Was Disclosed

Clorox filed its quarterly report for the period ended September 30, 2026, disclosing condensed consolidated statements of earnings, comprehensive income, balance sheets, and cash flows, along with an opening notes section covering basis of presentation and significant accounting policies.